Researchers at Duke University have shown that CRISPR genome editing technology can safely and stably correct Duchenne muscular dystrophy in mice.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.